Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) [Phase 1, Phase 2]
PMV Pharmaceuticals is evaluating PC14586 in a Phase 1/2 trial for advanced solid tumors harboring the TP53 Y220C mutation. The study is cur…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors [Phase 1, Phase 2]
A Mayo Clinic-sponsored phase 1/2 trial evaluating a personalized neoantigen peptide-based vaccine in combination with pembrolizumab for adv…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 study evaluating NKT5097 in adults with advanced or metastatic solid tumors, including various breast cancer subtypes and gynecologi…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: PROton Therapy for Post Surgical Treatment of GYNecologic Cancer [Phase 2]
A Phase 2 clinical trial evaluating proton therapy after surgery for gynecologic cancers (cervical, uterine/endometrial cancer) is currently…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
This clinical trial update describes the use of a live tumor diagnostic platform to evaluate immune checkpoint inhibitor responses across mu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers [Phase 1]
This Phase 1 clinical trial is evaluating talazoparib in combination with radiation therapy for locally recurrent gynecologic cancers, inclu…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-Endometrial01) [Phase 3]
Phase 3 clinical trial to compare GSK5733584 with chemotherapy in recurrent endometrial cancer. Recruitment has not yet begun.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
This document describes a Phase 1 trial evaluating the combination of niraparib and copanlisib in patients with recurrent endometrial, ovari…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer [Phase 1]
Phase I trial update evaluating safety and tolerability of chemoradiation followed by chemotherapy plus dostarlimab in stage IIIC, node-posi…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating cadonilimab (AK104) in combination with lenvatinib for advanced endometrial cancer; the study is currently…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors [Phase 1]
A Phase 1 clinical trial from AstraZeneca evaluating a KRAS G12D-targeted TCR-T cell therapy in adults with unresectable, advanced, or metas…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Abemaciclib and Letrozole to Treat Endometrial Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the combination of abemaciclib and letrozole for endometrial cancer. The study is currently active bu…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention [NA]
The study IGNITE-TX is a feasibility trial from MD Anderson Cancer Center to identify individuals for genetic testing and treatment across m…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Prediction of Recurrence Among Low Risk Endometrial Cancer Patients
A clinical trial update notes a study on predicting recurrence in low-risk endometrial cancer patients with FIGO grade 1–2 endometrioid aden…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Michigan Genetic Hereditary Testing (MiGHT) [NA]
The MiGHT hereditary genetic testing trial at the University of Michigan Rogel Cancer Center has completed, evaluating testing across multip…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers [NA]
Clinical trial update evaluating the feasibility of a weight loss intervention with or without resistance training for endometrial cancer su…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors [Phase 1]
Phase 1 trial of ALTA2618 for AKT1 E17K-mutant solid tumors is currently recruiting, with breast cancer and endometrial cancer among the ind…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Choices About Genetic Testing And Learning Your Risk With Smart Technology [NA]
A completed Rutgers-led trial evaluated choices about genetic testing and learning cancer risk using smart technology across multiple cancer…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology) [NA]
Medtronic MITG reports ongoing recruitment for the Hugo Robotic-Assisted Surgery System in gynecologic indications. The conditions being stu…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: QLS5132 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]
This update describes a Phase 1/2 study of QLS5132 combination therapy in multiple cancers, including gastric cancer, non-small cell lung ca…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking
Clinical trial evaluating trans-rectal ultrasound of the female pelvis to enable real-time MRI-ultrasound fusion for needle tracking in endo…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer
This clinical trial update describes a longitudinal study of women undergoing pelvic surgery for gynecologic cancers (cervical and endometri…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study of Lorigerlimab in Participants With Advanced Solid Tumors [Phase 2]
This is a Phase 2 clinical trial update for Lorigerlimab in participants with advanced solid tumors, currently recruiting, including platinu…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating STRO-004 in adults with refractory or recurrent metastatic cancer is currently recruiting, investigating…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: The LYSA (Linking You to Support and Advice) Trial [NA]
The LYSA trial (NCT05035173) has completed, with conditions listed including survivorship, breast cancer, cervical cancer, and endometrial c…